Edwards Lifesciences Corporation Company Profile

02:55 EST 20th November 2017 | BioPortfolio

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its market-leading heart valve therapies, and critical care and vascular technologies. In 2008, Edwards celebrates 50 years of partnering with clinicians to develop life-saving innovations. The company's global brands, which are sold in approximately 100 countries, include CardioVations, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at

News Articles [237 Associated News Articles listed on BioPortfolio]

Edwards Lifesciences To Present At The 12th Annual Wells Fargo Healthcare Conference

IRVINE, Calif., Aug. 31, 2017 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at ...

Q4 2017 EPS Estimates for Edwards Lifesciences Corporation (EW) Decreased by Leerink Swann

Edwards Lifesciences Corporation - Analysts at Leerink Swann reduced their Q4 2017 EPS estimates for shares of Edwards Lifesciences Corporation in a research note issued to investors on Thursday. Leer...

Edwards Lifesciences Corp. Bottom Line Advances 23% In Q3

WASHINGTON (dpa-AFX) - Edwards Lifesciences Corp. (EW) announced earnings for its third quarter that gained ground compared to the same period last year.The company said its bottom line came in at...

Edwards Lifesciences Corporation (EW) Issues Quarterly Earnings...

Edwards Lifesciences Corporation announced its earnings results on Monday. The medical research company reported $1.08 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.88...

Study shows positive results for Edwards Lifesciences' FORMA system

A study in JACC: Cardiovascular Interventions found the use of Edwards Lifesciences' FORMA system for severe tricuspid regurg -More- 

FDA approves Edwards Lifesciences' bioprosthetic heart valve

Edwards Lifesciences has obtained approval from the FDA for its Inspiris Resilia bioprosthetic heart valve, a surgical prosth -More- 

LivaNova, Edwards Lifesciences score reimbursement win for aortic valves

Rapid deployment valves, including Edwards Lifesciences' Intuity and LivaNova's Perceval aortic valves, have obtained new tec -More- 

Growth of Edwards Lifesciences requires $100 million campus renovation

Edwards Lifesciences, designers and manufacturers of the Sapien Transcatheter Heart Valve - the first aortic valve approved in the U.S. that doesn’t require open-heart surgery - have recently co...

PubMed Articles [26 Associated PubMed Articles listed on BioPortfolio]

Long-Term Clinical Outcomes of the Carpentier-Edwards Perimount Pericardial Bioprosthesis in Chinese Patients with Single or Multiple Valve Replacement in Aortic, Mitral, or Tricuspid Positions.

To report the safety and efficacy results of a 9- to 15-year follow-up investigation among patients who had received Carpentier-Edwards Perimount (CE-P) bovine pericardial bioprostheses (Edwards Lifes...

Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.

Residual aortic regurgitation (AR) after transfemoral aortic valve implantation (TAVI) is associated with increased mortality. The new Edwards Sapien 3 valve (ES3) is designed to reduce paravalvular A...

A Highly Predictive Risk Model for Pacemaker Implantation After TAVR.

This study sought to develop a robust and definitive risk model for new permanent pacemaker implantation (PPMI) after SAPIEN 3 (third generation balloon expandable valve) (Edwards Lifesciences, Irvine...

SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve.

Transcatheter aortic valve implantation (TAVI) has developed from a procedure for patients with aortic stenosis inoperable or high risk for surgery, into a treatment option even for intermediate risk ...

Medtronic Duran AnCore versus Edwards MC3 rings for tricuspid annuloplasty.

Ring annuloplasty is now regarded as the standard surgical technique for the correction of tricuspid regurgitation (TR). However, comparative research on the durability of commercially available annul...

Clinical Trials [51 Associated Clinical Trials listed on BioPortfolio]

Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population

To evaluate the safety and effectiveness of the SAPIEN XT (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic seve...

Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve Replacement (TMVR) Early Feasibility Study

Early feasibility study to evaluate the safety and function of the Edwards Lifesciences CardiAQ™ Transcatheter Mitral Valve

The PARTNER 3 - AVIV Trial

To assess the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve in patients with a failing aortic bioprosthetic valve.

PARTNER 3 Trial - Mitral Valve in Valve

To assess the safety and effectiveness of the SAPIEN 3 (Edwards Lifesciences, Irvine, California) transcatheter heart valve in patients with a failing mitral bioprosthetic valve.

COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction

This study will confirm the safety and effectiveness of the Edwards Lifesciences SAPIEN XT Transcatheter Heart Valve (THV) System in patients with a dysfunctional right ventricular outflow...

Companies [216 Associated Companies listed on BioPortfolio]

Edwards Lifesciences Corporation

Edwards Lifesciences is the global leader in the science of heart valves and hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treats advanced cardiovascular disease with its marke...

Edwards Lifesciences

Edwards Lifesciences Global Headquarters is located in Irvine, California, U.S.A. Our company supplies products and technologies to customers in more than 100 countries, through both direct sales and...

Vedic Lifesciences Pvt. Ltd.

Vedic Lifesciences, a Phase II/III CRO, also undertakes project management of Pre-Clinical Development Services for Pharma and Biotech Companies. We have an in-house team for Medical Affairs, Regulato...

Edwards Ltd

Further information about Edwards can be found at

Solace Lifesciences

Solace Lifesciences, the creators of NuCalm, is a pioneer in the fields of applied neuropsychobiology and bioinformatics. Founded in 2002, the company is dedicated to improving th...

More Information about "Edwards Lifesciences Corporation" on BioPortfolio

We have published hundreds of Edwards Lifesciences Corporation news stories on BioPortfolio along with dozens of Edwards Lifesciences Corporation Clinical Trials and PubMed Articles about Edwards Lifesciences Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Edwards Lifesciences Corporation Companies in our database. You can also find out about relevant Edwards Lifesciences Corporation Drugs and Medications on this site too.

Quick Search

Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Corporate Database Quicklinks

Searches Linking to this Company Record